AbbVie Inc. (ABBV) Class Action Lawsuit (October 2018)
Closed25-2369 • October 9, 2018
Class Period Start
October 25, 2013
Class Period End
September 18, 2018
PSLRA Deadline
November 20, 2018
Case Allegations
10b5
Statutes of Repose
Oct 25, 2016
Country
United States
Court
Federal Court
Docket History
Aug 20, 2025
Voluntary Dismissal (opens in a new tab)
The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.
Aug 8, 2025
Jul 10, 2025
Sep 23, 2021
Class Certification Granted (opens in a new tab)
The court has determined that a class action is the appropriate method to bring the claims by class members. Usually, when a class is certified, the judge will also affirm an individual or entity to represent the class and finalize a class definition (i.e.: who is represented in the lawsuit).
Jun 3, 2021
Apr 13, 2021
Apr 7, 2021
Feb 1, 2021
Motion for Class Certification (opens in a new tab)
The plaintiffs have asked the court to approve the lawsuit to proceed as a class action on behalf of a group of investors. The judge will decide whether the case meets the requirements for class certification and which investors and claims may be included.
Sep 1, 2020
Motion to Dismiss Denied (opens in a new tab)
The court has denied the defendants' request to dismiss the lawsuit. The case can now move forward to the next stage of litigation.
Sep 20, 2019
Motion to Dismiss (opens in a new tab)
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Jul 22, 2019
First Amended Complaint (opens in a new tab)
A new complaint has been filed on behalf of certain investors in AbbVie Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
May 13, 2019
Appointment of Lead Plaintiff (opens in a new tab)
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Oct 9, 2018
First Filed Complaint (opens in a new tab)
A securities fraud class action complaint has been filed on behalf of certain investors in AbbVie Inc..